Treatment time to the end of thoracic radiotherapy has more predictive power for survival than radiation dose intensity in patients with limited-stage small-cell lung cancer receiving concurrent chemoradiation of more than 45 Gy

The optimal protocol for thoracic radiotherapy (TRT) in combination with chemotherapy in patients with limited-stage small-cell lung cancer (LS-SCLC) remains elusive. The present study aimed to evaluate radiation parameters in association with survival outcomes. A total of 101 patients with LS-SCLC...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeong, Jae-Uk, Jeon, Wan, Ahn, Sung-Ja, Kim, Young-Chul, Oh, In-Jae, Park, Chul-Kyu, Yoon, Mee Sun, Song, Ju-Young, Nam, Taek-Keun, Chung, Woong-Ki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6924076/
https://www.ncbi.nlm.nih.gov/pubmed/31897135
http://dx.doi.org/10.3892/ol.2019.11107

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6924076/
https://www.ncbi.nlm.nih.gov/pubmed/31897135
http://dx.doi.org/10.3892/ol.2019.11107

Ejemplares similares